Image
World Arthritis Day And Global Implications Of “Don’t Delay, Connect Today” Module 1

Paul Emery, MD, MA, FRCP; Alan J. Kivitz, MD, CPI

Jointly provided by the Elsevier Office of Continuing Medical Education, Elsevier and Integritas Communications.

 

This activity has been supported by independent educational grants from Gilead Sciences, Inc., and Sanofi Genzyme and Regeneron Pharmaceuticals

Course Description

This CME/CE-accredited CME Snapshot™ series of educational videos has been created for rheumatologists and other clinicians involved in treating patients with rheumatoid arthritis (RA). During each 15-minute activity, two expert rheumatologists focus on a specific aspect of long-term RA management, including practical advice on implementing international treat-to-target guidelines as well as the mechanistic profiles and clinical evidence for therapies designed to inhibit signaling via interleukin-6 (IL-6) or members of the Janus kinase (JAK) family of enzymes. Some of the modules also include 3D-animated elements to illustrate the relationships between the heterogeneous pathophysiologic mechanisms underlying RA and certain targeted biologic or synthetic disease-modifying treatment options.

Target Audience

This activity has been designed to meet the educational needs of rheumatologists and other clinicians involved in the ongoing management of patients with RA.

Learning Outcome Statements

At the conclusion of this activity:

KNOWLEDGE: Participants will self-report knowledge gained based on current best practices and therapies for treating and managing Rheumatoid Arthritis.

COMPETENCE/SKILL: Participants will self-report intent to change practice by applying knowledge gained based on current best practices and therapies for treating and managing Rheumatoid Arthritis.

Educational Objectives

Upon completion of this activity, participants will be better able to do the following:

  • Implement treat-to-target strategies to reflect shared clinical decision making, comprehensive evaluations of RA activity and other patient-specific factors, and efforts to accelerate appropriately aggressive therapy

Faculty

Paul Emery, MD, MA, FRCP, FMedSci
Arthritis Research UK Professor of Rheumatology
Director, Leeds Musculoskeletal Biomedical Research Unit
Leeds Teaching Hospitals NHS Trust
Director, Leeds Institute of Rheumatic and Musculoskeletal Medicine
University of Leeds
Leeds, United Kingdom

Alan J. Kivitz, MD, CPI
President, Altoona Center for Clinical Research
President, Altoona Arthritis and Osteoporosis Center
Duncansville, Pennsylvania

Disclosure of Conflicts of Interest

It is the policy of the Elsevier Office of Continuing Medical Education that all faculty, instructors, and planners disclose any real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:

Paul Emery, MD, MA, FRCP: Consultant/Advisor: AbbVie Inc.; Bristol-Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Samsung Bioepis; Sandoz International GmbH; UCB, Inc.; Speakers’ Bureau: AbbVie Inc.; Bristol-Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Samsung Bioepis; Sandoz International GmbH; UCB, Inc.; Research Grant: AbbVie Inc.; Bristol-Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Samsung Bioepis; Sandoz International GmbH; UCB, Inc.

Alan J. Kivitz, MD, CPI: Consultant/Advisor: AbbVie Inc.; Vertex Pharmaceuticals Incorporated

Non-faculty

Rose O’Connor, PhD; Jim Kappler, PhD; Sandy Breslow; Alison Kemp; Marilu Kelly, MSN, RN, CNE; and Bernard M. Abrams, MD, hereby state that neither they nor their spouses/life partners have any financial relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. 

Financial Support

This activity has been supported by independent educational grants from Gilead Sciences, Inc., and Sanofi Genzyme and Regeneron Pharmaceuticals

CME Credit (Physicians) 

The Elsevier Office of Continuing Medical Education (EOCME) is accredited by the ACCME to provide continuing medical education for physicians.

The EOCME designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

CNE CREDIT (Nurses)

This continuing nursing education activity, provided by Elsevier, awards 0.25 contact hours for nurses. Elsevier is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Elsevier is provider approved by the Florida Board of Nursing, Provider #50-4681, and the California Board of Registered Nursing, Provider #CEP 3257.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of EOCME, Elsevier, and Integritas Communications.

CME Inquiries/Special Needs

For all CME inquiries or special needs, please contact elsevierCME@elsevier.com.

For all CNE inquiries or special needs, please contact p.harvey@elsevier.com.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Elsevier Office of Continuing Medical Education, Elsevier, Integritas Communications, Gilead Sciences, Inc., and Sanofi Genzyme and Regeneron Pharmaceuticals do not recommend the use of any agent outside of the labeled indications. 

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Course Instructions

In order to claim credit, participants must complete the following:

  1. Read the educational objectives, accreditation information, and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions.
  3. Read or review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Physicians who achieves a grade of 100% or better on the Post-Activity Test and who completes the Evaluation will receive a CME Certificate.
  6. Nurses who attain a grade of 100% on the post-activity test question and who complete the evaluation before the expiration date will receive a certificate of completion for 0.25 contact hours. There is no partial credit will be awarded for this activity. 
  7. All other participant who achieves a grade of 100% or better on the Post-Activity Test Questions and who completes the Evaluation will receive a Certificate of Participation.

Click "Begin Activity" to acknowledge that you have reviewed the preamble information for this activity.

Begin Activity

credit amount 0.25

credit type CME/CE

release 12/15/2017

expiration 12/15/2018

type SnapShot